Amplifon stock
Price history
−13.47% over the period1 year: from €13.44 (November 17, 2025) to €11.63 (November 17, 2026), −13.47%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | €11.63 |
| October 30, 2026 | €11.17 |
| September 30, 2026 | €12.10 |
| August 31, 2026 | €12.11 |
| July 31, 2026 | €12.15 |
| June 30, 2026 | €9.48 |
| May 29, 2026 | €10.78 |
| April 30, 2026 | €9.40 |
| March 31, 2026 | €9.40 |
| February 27, 2026 | €13.18 |
| January 30, 2026 | €13.59 |
| December 30, 2025 | €13.75 |
| November 28, 2025 | €13.24 |
| November 17, 2025 | €13.44 |
At a glance
The company
Distributes hearing solutions and customized products across Europe, Middle East, Africa, Americas and Asia Pacific
Latest results
Quarter to September 30, 2026 · EPS €0.09 (estimate €0.09)
Next event
TickerLandia's take on Amplifon
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 29 vs a median of 37 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 36 vs 28 (+27%) in a group of 11.
- Strong point: Dividend (66/100 in its group). Weak point: Financial strength (9/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−24.19% from the 52-week high
Analysts · 17 analysts
Average target€14.09+23.83% vs. price
Buy 8 · Hold 9 · Sell 0 · Buy
TickerLandia Fingerprint: Amplifon
Compared with similar companies: very low financial strength.
Financials and price compared with 11 companies in the medical distribution industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Priceaverage42
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 14.0 32 P/E (trailing 12 months) 35.7 68 EV/EBITDA 8.83 14 Price/book 2.10 17 Price/sales 1.32 77 Profitabilityhigh61
How much it earns on revenue and capital.
Metric Value Position in group ROE 5.7% 23 Gross margin 23.9% 77 Operating margin 10.3% 95 Net margin 3.0% 59 ROA 3.8% 50 Earnings stabilitylow34
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.7% 14 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 55 Growthlow20
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +4.17% 23 Revenue growth (year over year) +2.24% 14 Earnings growth (year over year) +5.50% 25 Financial strengthvery low9
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 3.88 5 Net debt/EBITDAcounts in reverse: lower means more financial strength 3.82 5 Debt/equitycounts in reverse: lower means more financial strength 1.18 23 Current ratio 0.73 5 Dividendhigh66
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 6 years 27 Dividend yield 2.6% 75 Payout ratio 93.2% 95 Market momentumaverage41
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −4.02% 39 Relative strength (6 months) +0.53% 61 1-year return −15.36% 14 Distance from 200-day average +1.69% 49 Riskhigh70
How much the price swings.
Metric Value Position in group Volatility (60 days) 46.5% 90 Beta (1 year) 0.53 30 Maximum drawdown (12 months) 43.2% 90
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Amplifon is cheaper than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Amplifon's P/E today is 28.8, below the median of its last 10 fiscal years (37.0; between 28.7 and 79.9 from 2016 to 2025). Amplifon's P/E (trailing 12 months): 35.7, +27% against the median of a group of 11 similar companies (28.2).
Compared with 11 similar companies
| Metric | Amplifon | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 35.7 | Middle | |
| Forward P/E | 14.0 | Middle | |
| Operating margin | 10.3% | High | |
| ROE | 5.7% | Low | |
| Debt/equity | 1.18 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Amplifon. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€575M
Latest quarter · Q3 2026
Net income
€9.4M
Latest quarter · Q3 2026
Quarterly net margin
1.6%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- €3.47B
- P/E
- 35.7
- EPS
- €0.31
- Volume
- 12.55M
- Daily trading
- €28.28M
- Dividend yield
- 2.55%
- Last ex-dividend on May 18, 2026
How Amplifon is changing
All resultsRevenue grew 9.8% a year on average over the last 5 years
Operating margin fell from 13.5% to 9.7%
Returns
Amplifon returns with dividends
€1,000 invested in Amplifon 5 years ago, on November 17, 2021, would be worth €283 today with dividends reinvested: −71.74% in total, −22.34% per year. On price alone it would be €264 (−73.56%).
| Period | Amplifon | FTSE MIB | €1,000 becomes |
|---|---|---|---|
| 1 month | −7.37% | +3.59% | €926 |
| 6 months | +4.07% | +3.52% | €1,041 |
| Year to date | −15.42% | +13.13% | €846 |
| 1 year | −11.14% | +16.17% | €889 |
| 3 years | −55.58% | +72.37% | €444 |
| 5 years | −71.74% | +82.73% | €283 |
| 10 years | +41.68% | +207.13% | €1,417 |
Over the last 6 months it has done better than 59% of the stocks in the Industrials sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. FTSE MIB: price only. Calculate your investment
The chart in detail
Amplifon: technical analysis
Amplifon shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 76.0% below its all-time closing high (€47.45, December 30, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 40
- Between 30 and 70
- vs 200-session average
- +1.69%
Support and resistance
Price areas where Amplifon has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€12.69+11.59%5 touches, last on August 14, 2026
- Resistance€12.32+8.31%2 touches, last on November 9, 2026
- Resistance€11.66+2.52%3 touches, last on August 20, 2026
- Last price€11.38
- Support€11.19−1.60%2 touches, last on September 10, 2026
- Support€10.94−3.81%3 touches, last on October 30, 2026
- Support€10.30−9.42%4 touches, last on June 8, 2026
Volatility and risk
Over the last year it has moved less than the FTSE MIB.
- Beta (1 year) vs FTSE MIB
- 0.53
- Volatility (60 sessions, annualised)
- 46.5%
- Largest fall in the last year
- −43.20%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Amplifon: seasonality
Average monthly price change over 26 years
Over the last 26 years, the strongest month for Amplifon has been May: +4.55% on average, positive in 14 years out of 25. The weakest has been November: −2.80% on average, positive in 11 years out of 25.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.84% | +1.39% | 14 of 25 |
| February | +1.99% | +2.58% | 19 of 25 |
| March | +3.34% | +6.97% | 18 of 25 |
| April | +4.01% | +3.08% | 17 of 25 |
| May | +4.55% | +2.56% | 14 of 25 |
| June | −1.30% | −0.56% | 11 of 25 |
| July | +1.41% | +3.37% | 15 of 26 |
| August | −0.80% | −1.26% | 9 of 26 |
| September | −1.98% | −1.84% | 11 of 26 |
| October | −0.20% | +0.74% | 14 of 26 |
| November | −2.80% | −0.25% | 11 of 25 |
| December | +3.90% | +3.41% | 17 of 25 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Amplifon and its competitors
Headquartered in Milan, Italy, Amplifon has existed since 1950 and distributes hearing solutions along with the fitting of customized products, helping people rediscover the many emotions of sound. Its range includes the Ampli-power and Ampli-mini hearing devices, while Ampli-care provides a platform for delivering audiological care and the Amplifon App lets users manage device functions in real time from a smartphone. The group operates across Europe, the Middle East, Africa, the Americas and the Asia Pacific region.
- Headquarters
- Milan, Italy
- Employees
- 11,792
- Founded
- 1950
- Chief executive
- Enrico Vita
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| AmplifonAMP | $3.81B | 10.3% | 35.7 | +4.07% |
| Asker Healthcare GroupASKER | $2.82B | 6.7% | 37.8 | −9.98% |
| GalenicaGALE | $5.42B | 4.8% | 28.3 | +9.59% |
| UnipharUPR | $1.25B | 2.9% | 20.8 | −0.93% |
| NEUCANEU | $801.3M | 2.0% | 16.7 | −0.42% |
| Sinopharm Group Ltd H1099 | $6.68B | 3.0% | 6.51 | −3.31% |
Same industry or related industries, similar size. Compare Amplifon with its competitors · Full profile
